Harvard Health Blog published an article on March 5th, 2018 with contributions from Dr. Carolyn Bernstein, an Osher Clinical Center service provider. This article discusses an exciting, new possibility for migraine treatment with Calcitonin gene-related peptide (CGRP) monoclonal antibodies.